FamiCord Group Nakiller
Filter by:
No. | Cell source | Indication | Area of medicine | Year | Type of therapy | Country | Age |
---|---|---|---|---|---|---|---|
1 | cord blood | talassemia major | hematology | 2018 | standard therapy | Turkey | 9,5 |
2 | autologous cord blood | aplastic anaemia | hematology | 2018 | standard therapy | Poland | 3,5 |
3 | cord blood | chronic granulomatous disease | hematology | 2017 | standard therapy | Turkey | 3,9 |
4 | autologous cord blood | autism | neurology | 2017 | experimental therapy | Poland | 4,1 |
5 | autologous cord blood | autism | neurology | 2017 | experimental therapy | Poland | 4,1 |
6 | autologous cord blood | autism | neurology | 2017 | experimental therapy | Poland | 5,4 |
7 | autologous cord blood | autism | neurology | 2017 | experimental therapy | Poland | 7,3 |
8 | autologous cord blood | autism | neurology | 2017 | experimental therapy | Poland | 6,2 |
9 | autologous cord blood | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6,8 |
10 | cord blood | relapse of acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 7,3 |
11 | autologous cord blood | autism | neurology | 2017 | experimental therapy | Poland | 4,11 |
12 | autologous cord blood | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 10,3 |
13 | autologous cord blood | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5,4 |
14 | autologous cord blood | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2,2 |
15 | cord blood | talassemia major | hematology | 2017 | standard therapy | Turkey | 4,1 |
16 | cord blood | talassemia major | hematology | 2017 | standard therapy | Turkey | 4,0 |
17 | cord blood | CD40 ligand deficiency | hematology | 2017 | standard therapy | Turkey | 9,6 |
18 | cord blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Hungary | 7 |
19 | autologous cord blood | autism | neurology | 2016 | experimental therapy | Poland | 6 |
20 | cord blood + peripheral blood | acute myeloid leukemia | hematology | 2016 | standard therapy | Jordan | 6 |
21 | cord blood | acute lymphoblastic leukemia | hematology | 2015 | standard therapy | Poland | 4 |
22 | cord blood | acute lymphoblastic leukemia | hematology | 2014 | standard therapy | Turkey | 7 |
23 | cord blood | X - linked lymphoproliferative syndrome | hematology | 2013 | standard therapy | Poland | 10/12 |
24 | cord blood | beta-talassemia, agranulocytosis | hematology | 2013 | standard therapy | Turkey | 8 |
25 | cord blood | acute myeloid leukemia | hematology | 2013 | standard therapy | Poland | 3 |
26 | cord blood | aplastic anaemia | hematology | 2013 | standard therapy | Poland | 3 |
27 | cord blood | T-acute lymphoblastic leukemia | hematology | 2012 | standard therapy | Turkey | 5 |
28 | cord blood | talassemia major, acute lymphoblastic leukemia | hematology | 2012 | standard therapy | Turkey | 3,5 |
29 | cord blood | anaemia, talassemia major | hematology | 2012 | standard therapy | Turkey | 6 |
30 | cord blood | severe aplastic anaemia | hematology | 2012 | standard therapy | Hungary | 3 |
31 | cord blood | chronic granulomatous disease | hematology | 2011 | standard therapy | Poland | 7,5 |
32 | cord blood | histiocytosis | hematology | 2011 | standard therapy | Poland | 2,5 |
33 | cord blood | acute lymphoblastic leukemia | hematology | 2011 | standard therapy | Poland | 5 |
34 | cord blood | acute myeloid leukemia | hematology | 2011 | standard therapy | Hungary | 2 |
35 | cord blood | Fanconi anemia | hematology | 2011 | standard therapy | Poland | 12 |
36 | cord blood | pre -B acute lymphoblastic leukemia | hematology | 2010 | standard therapy | Hungary | 1,5 |
37 | cord blood | myelodysplastic syndrome | hematology | 2009 | standard therapy | Poland | 5 |
38 | autologous cord blood | cerebral ischemia | neurology | 2008 | experimental therapy | Poland | 1,5 |
39 | cord blood | acute lymphoblastic leukemia | hematology | 2008 | standard therapy | Poland | 5 |
40 | cord blood | neuroblastoma | hematology | 2007 | standard therapy | Poland | 8 |
41 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2018 | experimental therapy | Poland | no data |
42 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 66,2 |
43 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 47,1 |
44 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 64,4 |
45 | cord tissue (Wharton's jelly) | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 10,9 |
46 | cord tissue (Wharton's jelly) | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 1,9 |
47 | cord tissue (Wharton's jelly) | autism | neurology | 2018 | experimental therapy | Poland | 9,5 |
48 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 70,11 |
49 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 40,9 |
50 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 31,2 |
51 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 60,2 |
52 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 65,2 |
53 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 65,7 |
54 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 22,6 |
55 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2018 | experimental therapy | Poland | 8,8 |
56 | cord tissue (Wharton's jelly) | holoprosencephalia | neurology | 2018 | experimental therapy | Poland | 12,2 |
57 | cord tissue (Wharton's jelly) | spinal cord injury | neurology | 2018 | experimental therapy | Poland | 25,9 |
58 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 80,5 |
59 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 35,1 |
60 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 54,4 |
61 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 76,1 |
62 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 9,4 |
63 | cord tissue (Wharton's jelly) | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 2,4 |
64 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 80,3 |
65 | cord tissue (Wharton's jelly) | dystrophia myotonica | neurology | 2018 | experimental therapy | Poland | 27,4 |
66 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 4,11 |
67 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 75,5 |
68 | cord tissue (Wharton's jelly) | Stargardt's disease | ophthalmology | 2018 | experimental therapy | Poland | 34,1 |
69 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 20,8 |
70 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 61,3 |
71 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 28,6 |
72 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 45,11 |
73 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 57,5 |
74 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 57,8 |
75 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 83,5 |
76 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 35 |
77 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 41,9 |
78 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 67,11 |
79 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2018 | experimental therapy | Poland | 7,0 |
80 | cord tissue (Wharton's jelly) | damage to the intercondylar fissure of the right knee | orthopedics | 2018 | experimental therapy | Poland | 40,2 |
81 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 54,2 |
82 | cord tissue (Wharton's jelly) | encephalopathy | neurology | 2018 | experimental therapy | Poland | 54,8 |
83 | cord tissue (Wharton's jelly) | autism | neurology | 2018 | experimental therapy | Poland | 6,10 |
84 | cord tissue (Wharton's jelly) | autism | neurology | 2018 | experimental therapy | Poland | 8,3 |
85 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 2,11 |
86 | cord tissue (Wharton's jelly) | autism | neurology | 2018 | experimental therapy | Poland | 9,0 |
87 | cord tissue (Wharton's jelly) | developmental delay | neurology | 2018 | experimental therapy | Poland | 7,11 |
88 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 40,0 |
89 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 21,7 |
90 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 62,5 |
91 | cord tissue (Wharton's jelly) | autism | neurology | 2018 | experimental therapy | Poland | 8,5 |
92 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 3,8 |
93 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 28,6 |
94 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 52,11 |
95 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 47,3 |
96 | cord tissue (Wharton's jelly) | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 46,1 |
97 | cord tissue (Wharton's jelly) | Friedreich's ataxia | neurology | 2018 | experimental therapy | Poland | 31,5 |
98 | cord tissue (Wharton's jelly) | Friedreich's ataxia | neurology | 2018 | experimental therapy | Poland | 27,6 |
99 | cord tissue (Wharton's jelly) | stroke | neurology | 2018 | experimental therapy | Poland | 70,1 |
100 | cord tissue (Wharton's jelly) | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 9,2 |
101 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 55,8 |
102 | cord tissue (Wharton's jelly) | age-related macular degeneration | ophthalmology | 2018 | experimental therapy | Poland | 20,6 |
103 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 34,2 |
104 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 44,2 |
105 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 30,4 |
106 | cord tissue (Wharton's jelly) | age-related macular degeneration | ophthalmology | 2018 | experimental therapy | Poland | 46,7 |
107 | cord tissue (Wharton's jelly) | epilepsia | neurology | 2018 | experimental therapy | Poland | 20,9 |
108 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 65,2 |
109 | cord tissue (Wharton's jelly) | spinal cord injury | neurology | 2018 | experimental therapy | Poland | 30,9 |
110 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 38,1 |
111 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 46,2 |
112 | cord tissue (Wharton's jelly) | developmental delay | neurology | 2018 | experimental therapy | Poland | 14 |
113 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 38,6 |
114 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 51,9 |
115 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 50,8 |
116 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 59,3 |
117 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 47,8 |
118 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 66,3 |
119 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 52,3 |
120 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2018 | experimental therapy | Poland | 33,11 |
121 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2018 | experimental therapy | Poland | 3,1 |
122 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 27,2 |
123 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 34,11 |
124 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 36,6 |
125 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 55,4 |
126 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 39,5 |
127 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 46,7 |
128 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 32,3 |
129 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 41,8 |
130 | cord tissue (Wharton's jelly) | degeneration of the cartilage of the knee joint | orthopedics | 2018 | experimental therapy | Poland | 34,7 |
131 | cord tissue (Wharton's jelly) | other specific disorders of the central nervous system | neurology | 2018 | experimental therapy | Poland | 1,11 |
132 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 67,10 |
133 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 66,8 |
134 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2018 | experimental therapy | Poland | 28,1 |
135 | cord tissue (Wharton's jelly) | myopathy | neurology | 2018 | experimental therapy | Poland | 57,3 |
136 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2018 | experimental therapy | Poland | 2,6 |
137 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 52,8 |
138 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 44,3 |
139 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 48,11 |
140 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2018 | experimental therapy | Poland | 59,10 |
141 | cord tissue (Wharton's jelly) | cerebral palsy, epilepsy | neurology | 2018 | experimental therapy | Poland | 3,7 |
142 | cord tissue (Wharton's jelly) | gonarthrosis | orthopedics | 2018 | experimental therapy | Poland | 44,11 |
143 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2018 | experimental therapy | Poland | 16,7 |
144 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2018 | experimental therapy | Poland | 61,11 |
145 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 36,3 |
146 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2018 | experimental therapy | Poland | 25,5 |
147 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 31,11 |
148 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2018 | experimental therapy | Poland | 68,5 |
149 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 71,8 |
150 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 57,1 |
151 | cord tissue (Wharton's jelly) | anterior ischemic optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 67,7 |
152 | cord tissue (Wharton's jelly) | moyamoya disease | neurology | 2017 | experimental therapy | Poland | 17,7 |
153 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 9/12 |
154 | cord tissue (Wharton's jelly) | optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 7,11 |
155 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6,2 |
156 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2,5 |
157 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 48,2 |
158 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 14,4 |
159 | cord tissue (Wharton's jelly) | epilepsia | neurology | 2017 | experimental therapy | Poland | 15,9 |
160 | cord tissue (Wharton's jelly) | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 8,3 |
161 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 48,8 |
162 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 66,10 |
163 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 7,6 |
164 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 1,6 |
165 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 7,8 |
166 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6,2 |
167 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 45,3 |
168 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 36,9 |
169 | cord tissue (Wharton's jelly) | cerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 33,0 |
170 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 7,4 |
171 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 8,6 |
172 | cord tissue (Wharton's jelly) | other specific disorders of the central nervous system | neurology | 2017 | experimental therapy | Poland | 2,4 |
173 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 54,2 |
174 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 6,5 |
175 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2,8 |
176 | cord tissue (Wharton's jelly) | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 46,5 |
177 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 59,0 |
178 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 43,10 |
179 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 37,1 |
180 | cord tissue (Wharton's jelly) | cartilage damage | orthopedics | 2017 | experimental therapy | Poland | 46,10 |
181 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 64,3 |
182 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 69,2 |
183 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 5,10 |
184 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5,9 |
185 | cord tissue (Wharton's jelly) | autism, encephalopathy | neurology | 2017 | experimental therapy | Poland | 7,11 |
186 | cord tissue (Wharton's jelly) | cerebral palsy, epilepsy | neurology | 2017 | experimental therapy | Poland | 2,1 |
187 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 52,8 |
188 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5,6 |
189 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 17,0 |
190 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 10,9 |
191 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 65,10 |
192 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 61,7 |
193 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 78,5 |
194 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 29,8 |
195 | cord tissue (Wharton's jelly) | spinocerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 24,6 |
196 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2,8 |
197 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 10,3 |
198 | cord tissue (Wharton's jelly) | congenital malformations of the nervous system, unspecified | neurology | 2017 | experimental therapy | Poland | 8,2 |
199 | cord tissue (Wharton's jelly) | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 60,11 |
200 | cord tissue (Wharton's jelly) | spinocerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 35,9 |
201 | cord tissue (Wharton's jelly) | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 52,6 |
202 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 8,0 |
203 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 1,6 |
204 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 28,7 |
205 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 60,1 |
206 | cord tissue (Wharton's jelly) | other specific disorders of the central nervous system | neurology | 2017 | experimental therapy | Poland | 2,1 |
207 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 85,7 |
208 | cord tissue (Wharton's jelly) | gonarthrosis | orthopedics | 2017 | experimental therapy | Poland | 66,8 |
209 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 12,2 |
210 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 8,1 |
211 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2017 | experimental therapy | Poland | 14,5 |
212 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 38,4 |
213 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 24,8 |
214 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 11,10 |
215 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4,2 |
216 | cord tissue (Wharton's jelly) | spinal cord injury, tetraparesis | orthopedics | 2017 | experimental therapy | Poland | 42,9 |
217 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 5,10 |
218 | cord tissue (Wharton's jelly) | tetraparesis spastica, epilepsia | neurology | 2017 | experimental therapy | Poland | 2,8 |
219 | cord tissue (Wharton's jelly) | hypoxia-ischemic encephalopathy | neurology | 2017 | experimental therapy | Poland | 1,10 |
220 | cord tissue (Wharton's jelly) | gonarthrosis | orthopedics | 2017 | experimental therapy | Poland | 65,6 |
221 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 61,3 |
222 | cord tissue (Wharton's jelly) | epilepsia | neurology | 2017 | experimental therapy | Poland | 12,11 |
223 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 3,4 |
224 | cord tissue (Wharton's jelly) | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 37,8 |
225 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 78,7 |
226 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 44,0 |
227 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 22,10 |
228 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 1,11 |
229 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4,6 |
230 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 32,9 |
231 | cord tissue (Wharton's jelly) | encephalopathy | neurology | 2017 | experimental therapy | Poland | 1,6 |
232 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 10,0 |
233 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6,2 |
234 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 7,8 |
235 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 18,5 |
236 | cord tissue (Wharton's jelly) | delayed psychomotor development, epilepsia | neurology | 2017 | experimental therapy | Poland | 11,8 |
237 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2017 | experimental therapy | Poland | 9,10 |
238 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 22,4 |
239 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 43,11 |
240 | cord tissue (Wharton's jelly) | condition after myelitis | neurology | 2017 | experimental therapy | Poland | 34,11 |
241 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 33,8 |
242 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 78,6 |
243 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 30,6 |
244 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 77,5 |
245 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 54,6 |
246 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 2,3 |
247 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 65,4 |
248 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 47,6 |
249 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4,9 |
250 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3,0 |
251 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 27,3 |
252 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4,2 |
253 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2,3 |
254 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3,3 |
255 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | b/d |
256 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 53,10 |
257 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 55,2 |
258 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2,4 |
259 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 13,6 |
260 | cord tissue (Wharton's jelly) | cerebral palsy, epilepsy | neurology | 2017 | experimental therapy | Poland | 3,6 |
261 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 15,3 |
262 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4,11 |
263 | cord tissue (Wharton's jelly) | epilepsia | neurology | 2017 | experimental therapy | Poland | 9,11 |
264 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 8,10 |
265 | cord tissue (Wharton's jelly) | tetraparesis | orthopedics | 2017 | experimental therapy | Poland | 27,11 |
266 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | b/d |
267 | cord tissue (Wharton's jelly) | epilepsia | neurology | 2017 | experimental therapy | Poland | 16,4 |
268 | cord tissue (Wharton's jelly) | atrophy of the optic nerves | ophthalmology | 2017 | experimental therapy | Poland | 35,5 |
269 | cord tissue (Wharton's jelly) | leukodystrophy | neurology | 2017 | experimental therapy | Poland | 7,1 |
270 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 53,9 |
271 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 46,5 |
272 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 59,11 |
273 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 57,9 |
274 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 62,9 |
275 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 63,0 |
276 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 4,8 |
277 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4,7 |
278 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3,2 |
279 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 58,7 |
280 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 25,2 |
281 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 38,0 |
282 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 56,7 |
283 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 10,8 |
284 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 4,11 |
285 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 2,8 |
286 | cord tissue (Wharton's jelly) | global developmental delay | neurology | 2017 | experimental therapy | Poland | 7,11 |
287 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 60,1 |
288 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 49,1 |
289 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 59,3 |
290 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 68,1 |
291 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 2,7 |
292 | cord tissue (Wharton's jelly) | myopathy of congenital fiber type disproportion, damage to the central nervous system | neurology | 2017 | experimental therapy | Poland | 2,2 |
293 | cord tissue (Wharton's jelly) | epilepsia, autism | neurology | 2017 | experimental therapy | Poland | 6,0 |
294 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5,3 |
295 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 6,10 |
296 | cord tissue (Wharton's jelly) | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 31,3 |
297 | cord tissue (Wharton's jelly) | Devic’s disease | neurology | 2017 | experimental therapy | Poland | 45,2 |
298 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3,4 |
299 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5,1 |
300 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3,5 |
301 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3,7 |
302 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5,5 |
303 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 7,9 |
304 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 13,1 |
305 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 10,8 |
306 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 18,4 |
307 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 26,9 |
308 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 12,10 |
309 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 51,3 |
310 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 5,8 |
311 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 15,1 |
312 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 8,4 |
313 | cord tissue (Wharton's jelly) | encephalopathy | neurology | 2017 | experimental therapy | Poland | 5,5 |
314 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 65,1 |
315 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 70,11 |
316 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 51,6 |
317 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 64,7 |
318 | cord tissue (Wharton's jelly) | optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 74,5 |
319 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 43,8 |
320 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3,7 |
321 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /BMD | neurology | 2017 | experimental therapy | Poland | 23,9 |
322 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 76,10 |
323 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 63,2 |
324 | cord tissue (Wharton's jelly) | dystrophia myotonica | neurology | 2017 | experimental therapy | Poland | 3,2 |
325 | cord tissue (Wharton's jelly) | arthrogryposis multiplex congenita | neurology | 2017 | experimental therapy | Poland | 3,5 |
326 | cord tissue (Wharton's jelly) | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 7,9 |
327 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 2,11 |
328 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 3,4 |
329 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 8,2 |
330 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 4,8 |
331 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 39,7 |
332 | cord tissue (Wharton's jelly) | optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 30,11 |
333 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 2,4 |
334 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 42,1 |
335 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 33,4 |
336 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 3,6 |
337 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 4,1 |
338 | cord tissue (Wharton's jelly) | optic neuropathy | ophthalmology | 2017 | experimental therapy | Poland | 56,4 |
339 | cord tissue (Wharton's jelly) | global developmental delay | neurology | 2017 | experimental therapy | Poland | 4,7 |
340 | cord tissue (Wharton's jelly) | dystrophia myotonica | neurology | 2017 | experimental therapy | Poland | 41,11 |
341 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 54,10 |
342 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 46,9 |
343 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 32,3 |
344 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 6,7 |
345 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 13,6 |
346 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 7,0 |
347 | cord tissue (Wharton's jelly) | encephalopathy, cerebral palsy | neurology | 2017 | experimental therapy | Poland | 1,5 |
348 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 6,8 |
349 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 1,10 |
350 | cord tissue (Wharton's jelly) | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 35,4 |
351 | cord tissue (Wharton's jelly) | condition after encephalitis | neurology | 2017 | experimental therapy | Poland | 19,7 |
352 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 49,1 |
353 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 46,0 |
354 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 6,3 |
355 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 6,4 |
356 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 4,8 |
357 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 6,1 |
358 | cord tissue (Wharton's jelly) | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 60,5 |
359 | cord tissue (Wharton's jelly) | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 62,5 |
360 | cord tissue (Wharton's jelly) | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 48,10 |
361 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 31,5 |
362 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 45,5 |
363 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 51,6 |
364 | cord tissue (Wharton's jelly) | spinocerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 24,6 |
365 | cord tissue (Wharton's jelly) | Krabbe disease | neurology | 2017 | experimental therapy | Poland | 6,3 |
366 | cord tissue (Wharton's jelly) | hypoxia-ischemic encephalopathy | neurology | 2017 | experimental therapy | Poland | 1,9 |
367 | cord tissue (Wharton's jelly) | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 5,0 |
368 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 3,3 |
369 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5,9 |
370 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 12,5 |
371 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 5,7 |
372 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 33,5 |
373 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 10,2 |
374 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 31,9 |
375 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 31,9 |
376 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 35,6 |
377 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 63,11 |
378 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 36,11 |
379 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 77,2 |
380 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4,11 |
381 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 35,1 |
382 | cord tissue (Wharton's jelly) | ischemia within the optic nerve | ophthalmology | 2017 | experimental therapy | Poland | 37,11 |
383 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 66,11 |
384 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 11,10 |
385 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2017 | experimental therapy | Poland | 13,0 |
386 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 52,0 |
387 | cord tissue (Wharton's jelly) | syndrom IFAP | hematology | 2017 | experimental therapy | Poland | 3,5 |
388 | cord tissue (Wharton's jelly) | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 6,3 |
389 | cord tissue (Wharton's jelly) | delayed psychomotor development | neurology | 2017 | experimental therapy | Poland | 3,5 |
390 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 7,11 |
391 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 6,3 |
392 | cord tissue (Wharton's jelly) | hydrocephalus, neonatal cerebral leukomalacia | neurology | 2017 | experimental therapy | Poland | 2,3 |
393 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 31,6 |
394 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 34,10 |
395 | cord tissue (Wharton's jelly) | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 45,4 |
396 | cord tissue (Wharton's jelly) | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 27,11 |
397 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 52,11 |
398 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 31,1 |
399 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 37,7 |
400 | cord tissue (Wharton's jelly) | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 24,9 |
401 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 69,10 |
402 | cord tissue (Wharton's jelly) | no bone adhesion | orthopedics | 2017 | experimental therapy | Poland | 17,11 |
403 | cord tissue (Wharton's jelly) | no bone adhesion | orthopedics | 2017 | experimental therapy | Poland | 14,1 |
404 | cord tissue (Wharton's jelly) | traumatic brain injury | neurology | 2017 | experimental therapy | Poland | 9,4 |
405 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 15,4 |
406 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 6,4 |
407 | cord tissue (Wharton's jelly) | cerebral palsy, epilepsy | neurology | 2017 | experimental therapy | Poland | 5,8 |
408 | cord tissue (Wharton's jelly) | encephalopathy, cerebral palsy | neurology | 2017 | experimental therapy | Poland | 4,4 |
409 | cord tissue (Wharton's jelly) | arthrogryposis multiplex congenita | neurology | 2017 | experimental therapy | Poland | 1,7 |
410 | cord tissue (Wharton's jelly) | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 37,11 |
411 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2017 | experimental therapy | Poland | 1,11 |
412 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 48,1 |
413 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 40,11 |
414 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 61,5 |
415 | cord tissue (Wharton's jelly) | chronic myeloid leukemia | hematology | 2017 | experimental therapy | Poland | 5,11 |
416 | cord tissue (Wharton's jelly) | congenital fiber-type disproportion myopathy | neurology | 2017 | experimental therapy | Poland | 1,10 |
417 | cord tissue (Wharton's jelly) | cerebellar syndrome | neurology | 2017 | experimental therapy | Poland | 11,5 |
418 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 9,1 |
419 | cord tissue (Wharton's jelly) | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 26,10 |
420 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 11,11 |
421 | cord tissue (Wharton's jelly) | cerebral palsy, neonatal cerebral leukomalacia | neurology | 2017 | experimental therapy | Poland | 1,9 |
422 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 52,1 |
423 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 41,0 |
424 | cord tissue (Wharton's jelly) | encephalopathy | neurology | 2017 | experimental therapy | Poland | 5,0 |
425 | cord tissue (Wharton's jelly) | encephalopathy | neurology | 2017 | experimental therapy | Poland | 21,10 |
426 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 13,4 |
427 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 56,7 |
428 | cord tissue (Wharton's jelly) | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 38,5 |
429 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 47,2 |
430 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 64,9 |
431 | cord tissue (Wharton's jelly) | syringomielia | neurology | 2017 | experimental therapy | Poland | 42,6 |
432 | cord tissue (Wharton's jelly) | transverse myelitis | neurology | 2017 | experimental therapy | Poland | 8,3 |
433 | cord tissue (Wharton's jelly) | cranium bifidum | neurology | 2017 | experimental therapy | Poland | 5,2 |
434 | cord tissue (Wharton's jelly) | epilepsia | neurology | 2017 | experimental therapy | Poland | 3,1 |
435 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2017 | experimental therapy | Poland | 28,11 |
436 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 22,1 |
437 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 59,8 |
438 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2017 | experimental therapy | Poland | 18,7 |
439 | cord tissue (Wharton's jelly) | cri du chat syndrome | neurology | 2017 | experimental therapy | Poland | 8,6 |
440 | cord tissue (Wharton's jelly) | gonarthrosis | orthopedics | 2017 | experimental therapy | Poland | 58,9 |
441 | cord tissue (Wharton's jelly) | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 8,5 |
442 | cord tissue (Wharton's jelly) | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 12,11 |
443 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 30,9 |
444 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 42,11 |
445 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 39,0 |
446 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 51,3 |
447 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2017 | experimental therapy | Poland | 39,0 |
448 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 43,4 |
449 | cord tissue (Wharton's jelly) | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 23,7 |
450 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 75,9 |
451 | cord tissue (Wharton's jelly) | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 25,8 |
452 | cord tissue (Wharton's jelly) | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 41,4 |
453 | cord tissue (Wharton's jelly) | limb-girdle muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 44,2 |
454 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2017 | experimental therapy | Poland | 28,6 |
455 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 45,9 |
456 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 65,2 |
457 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 56,8 |
458 | cord tissue (Wharton's jelly) | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 30,0 |
459 | cord tissue (Wharton's jelly) | spinal muscular atrophy | neurology | 2017 | experimental therapy | Poland | 10,6 |
460 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 24,9 |
461 | cord tissue (Wharton's jelly) | tetraparesis spastica | neurology | 2017 | experimental therapy | Poland | 29,4 |
462 | cord tissue (Wharton's jelly) | age-related macular degeneration | ophthalmology | 2017 | experimental therapy | Poland | 33,4 |
463 | cord tissue (Wharton's jelly) | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 31,6 |
464 | cord tissue (Wharton's jelly) | atrophy of the optic nerves | ophthalmology | 2017 | experimental therapy | Poland | 23,9 |
465 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2017 | experimental therapy | Poland | 52,9 |
466 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 34,1 |
467 | cord tissue (Wharton's jelly) | cartilage damage | orthopedics | 2017 | experimental therapy | Poland | 61,5 |
468 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 46,3 |
469 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 48,11 |
470 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 56,7 |
471 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2017 | experimental therapy | Poland | 26,11 |
472 | cord tissue (Wharton's jelly) | dystrophia myotonica | neurology | 2017 | experimental therapy | Poland | 37,7 |
473 | cord tissue (Wharton's jelly) | Stargardt's disease | ophthalmology | 2017 | experimental therapy | Poland | 37,4 |
474 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 49,0 |
475 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2017 | experimental therapy | Poland | 58,10 |
476 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2017 | experimental therapy | Poland | 34,11 |
477 | cord tissue (Wharton's jelly) | spinocerebellar ataxia | neurology | 2017 | experimental therapy | Poland | 44,1 |
478 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 47,6 |
479 | cord tissue (Wharton's jelly) | autism | neurology | 2017 | experimental therapy | Poland | 7,11 |
480 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | no data |
481 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 71,7 |
482 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 37,9 |
483 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2017 | experimental therapy | Poland | 67,11 |
484 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55,5 |
485 | cord tissue (Wharton's jelly) | premature ovarian failure | ginecology | 2016 | experimental therapy | Poland | 34,9 |
486 | cord tissue (Wharton's jelly) | premature ovarian failure | ginecology | 2016 | experimental therapy | Poland | 23,4 |
487 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 60,8 |
488 | cord tissue (Wharton's jelly) | meniscus damage | orthopedics | 2016 | experimental therapy | Poland | 35,5 |
489 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 44,5 |
490 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 38,4 |
491 | cord tissue (Wharton's jelly) | endometrial atrophy | ginecology | 2016 | experimental therapy | Poland | 39,1 |
492 | cord tissue (Wharton's jelly) | endometrial atrophy | ginecology | 2016 | experimental therapy | Poland | 37,3 |
493 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 33,4 |
494 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 31,11 |
495 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 15,0 |
496 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /BMD | neurology | 2016 | experimental therapy | Poland | 19,2 |
497 | cord tissue (Wharton's jelly) | degeneration of the cartilage of the knee joint | orthopedics | 2016 | experimental therapy | Poland | 54,3 |
498 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 44,8 |
499 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61,2 |
500 | cord tissue (Wharton's jelly) | tetraparesis | orthopedics | 2016 | experimental therapy | Poland | 27,2 |
501 | cord tissue (Wharton's jelly) | neurodevelopmental disorders | neurology | 2016 | experimental therapy | Poland | 4,5 |
502 | cord tissue (Wharton's jelly) | cerebellar syndrome | neurology | 2016 | experimental therapy | Poland | 28,6 |
503 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2016 | experimental therapy | Poland | 4,9 |
504 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 4,4 |
505 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 10 |
506 | cord tissue (Wharton's jelly) | limb-girdle muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 44,7 |
507 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 4,8 |
508 | cord tissue (Wharton's jelly) | cartilage damage | orthopedics | 2016 | experimental therapy | Poland | 57,6 |
509 | cord tissue (Wharton's jelly) | injuries to the spinal nerves | neurology | 2016 | experimental therapy | Poland | 5/12 |
510 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 17,9 |
511 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 3,7 |
512 | cord tissue (Wharton's jelly) | epilepsia | neurology | 2016 | experimental therapy | Poland | 16,2 |
513 | cord tissue (Wharton's jelly) | optic neuropathy | ophthalmology | 2016 | experimental therapy | Poland | 33,5 |
514 | cord tissue (Wharton's jelly) | myopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophy | ophthalmology | 2016 | experimental therapy | Poland | 37,1 |
515 | cord tissue (Wharton's jelly) | Stargardt's disease | ophthalmology | 2016 | experimental therapy | Poland | 37,7 |
516 | cord tissue (Wharton's jelly) | diffuse cartilage damage left medial compartment of the knee | orthopedics | 2016 | experimental therapy | Poland | 50,5 |
517 | cord tissue (Wharton's jelly) | polineuropathy | neurology | 2016 | experimental therapy | Poland | 70,8 |
518 | cord tissue (Wharton's jelly) | epileptic encephalopathy | neurology | 2016 | experimental therapy | Poland | 3,6 |
519 | cord tissue (Wharton's jelly) | epilepsia | neurology | 2016 | experimental therapy | Poland | 14,9 |
520 | cord tissue (Wharton's jelly) | gangliosidosis t. 1 | neurology | 2016 | experimental therapy | Poland | 1,4 |
521 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | no data |
522 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66,10 |
523 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 56,3 |
524 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 48,1 |
525 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 4,1 |
526 | cord tissue (Wharton's jelly) | tetraparesis spastica | orthopedics | 2016 | experimental therapy | Poland | 18 |
527 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2016 | experimental therapy | Poland | 2,11 |
528 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 56,8 |
529 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 72,1 |
530 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 41,2 |
531 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55,4 |
532 | cord tissue (Wharton's jelly) | chondronecrosis femoral condyle | orthopedics | 2016 | experimental therapy | Poland | 54,11 |
533 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 68,2 |
534 | cord tissue (Wharton's jelly) | tetraparesis spastica | orthopedics | 2016 | experimental therapy | Poland | 58,4 |
535 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 13,10 |
536 | cord tissue (Wharton's jelly) | fetal alcohol spectrum disorders | neurology | 2016 | experimental therapy | Poland | 5,2 |
537 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 20,9 |
538 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 49,3 |
539 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 51,9 |
540 | cord tissue (Wharton's jelly) | spinocerebellar ataxia | neurology | 2016 | experimental therapy | Poland | 41,8 |
541 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 6 |
542 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 16,4 |
543 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 10,3 |
544 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 6,8 |
545 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2016 | experimental therapy | Poland | 15,9 |
546 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66,7 |
547 | cord tissue (Wharton's jelly) | Stargardt's disease | ophthalmology | 2016 | experimental therapy | Poland | 24,5 |
548 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 9,2 |
549 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 44,5 |
550 | cord tissue (Wharton's jelly) | chronic graft versus host disease | hematology | 2016 | experimental therapy | Poland | 8/12 |
551 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 68,5 |
552 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 29,7 |
553 | cord tissue (Wharton's jelly) | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 1,10 |
554 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 7,6 |
555 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 1,10 |
556 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 60,7 |
557 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 71,5 |
558 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 52,7 |
559 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 65,9 |
560 | cord tissue (Wharton's jelly) | limb-girdle muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 32,3 |
561 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 34, 7 |
562 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 24,5 |
563 | cord tissue (Wharton's jelly) | patella cartilage damage | orthopedics | 2016 | experimental therapy | Poland | 53 |
564 | cord tissue (Wharton's jelly) | atrophy of the optic nerves | ophthalmology | 2016 | experimental therapy | Poland | 20,11 |
565 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 59,4 |
566 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | no data |
567 | cord tissue (Wharton's jelly) | encephalopathy | neurology | 2016 | experimental therapy | Poland | 4,3 |
568 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2016 | experimental therapy | Poland | 2,11 |
569 | cord tissue (Wharton's jelly) | encephalopathy | neurology | 2016 | experimental therapy | Poland | 3 |
570 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 10,8 |
571 | cord tissue (Wharton's jelly) | patella cartilage damage | orthopedics | 2016 | experimental therapy | Poland | 60,8 |
572 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 53,4 |
573 | cord tissue (Wharton's jelly) | no data | ophthalmology | 2016 | experimental therapy | Poland | 66,1 |
574 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 31,9 |
575 | cord tissue (Wharton's jelly) | ataxia hereditaria | neurology | 2016 | experimental therapy | Poland | 69 |
576 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 31,9 |
577 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 37,11 |
578 | cord tissue (Wharton's jelly) | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 17,10 |
579 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 30,3 |
580 | cord tissue (Wharton's jelly) | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 34,2 |
581 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 59,6 |
582 | cord tissue (Wharton's jelly) | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 3,3 |
583 | cord tissue (Wharton's jelly) | developmental delay | neurology | 2016 | experimental therapy | Poland | 2,7 |
584 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2016 | experimental therapy | Poland | 1,3 |
585 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 12,3 |
586 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 12,11 |
587 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 5,0 |
588 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 2,2 |
589 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 13,7 |
590 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 68,5 |
591 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 54,6 |
592 | cord tissue (Wharton's jelly) | age-related macular degeneration | ophthalmology | 2016 | experimental therapy | Poland | 86,5 |
593 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 23,6 |
594 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61,2 |
595 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 49,3 |
596 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 47,11 |
597 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 14,4 |
598 | cord tissue (Wharton's jelly) | spinocerebellar ataxia | neurology | 2016 | experimental therapy | Poland | 54,3 |
599 | cord tissue (Wharton's jelly) | optic neuropathy | ophthalmology | 2016 | experimental therapy | Poland | 79,8 |
600 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 3 |
601 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 8,4 |
602 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 38,1 |
603 | cord tissue (Wharton's jelly) | optic neuropathy | ophthalmology | 2016 | experimental therapy | Poland | 66 |
604 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2016 | experimental therapy | Poland | 7,4 |
605 | cord tissue (Wharton's jelly) | developmental delay | neurology | 2016 | experimental therapy | Poland | 7,4 |
606 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 13,2 |
607 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 39,6 |
608 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66,8 |
609 | cord tissue (Wharton's jelly) | global developmental delay | neurology | 2016 | experimental therapy | Poland | 6,9 |
610 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 9,9 |
611 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 3 |
612 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2016 | experimental therapy | Poland | 1,5 |
613 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2016 | experimental therapy | Poland | 4,8 |
614 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 58,1 |
615 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55,7 |
616 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 49,4 |
617 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55,9 |
618 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66,2 |
619 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 12,6 |
620 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 58,10 |
621 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 62,6 |
622 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55,9 |
623 | cord tissue (Wharton's jelly) | epilepsia | neurology | 2016 | experimental therapy | Poland | 14,7 |
624 | cord tissue (Wharton's jelly) | limb-girdle muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 22 |
625 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 50,9 |
626 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 54,2 |
627 | cord tissue (Wharton's jelly) | adrenoleukodystrophy | neurology | 2016 | experimental therapy | Poland | 9,7 |
628 | cord tissue (Wharton's jelly) | adrenoleukodystrophy | neurology | 2016 | experimental therapy | Poland | 6,11 |
629 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 48,4 |
630 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 72,6 |
631 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 79,2 |
632 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61,4 |
633 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 45,8 |
634 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 61,11 |
635 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2016 | experimental therapy | Poland | 3,11 |
636 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 32,7 |
637 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 48,3 |
638 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61,6 |
639 | cord tissue (Wharton's jelly) | leukodystrophy | neurology | 2016 | experimental therapy | Poland | 2,11 |
640 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 73,7 |
641 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 60,4 |
642 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 7,4 |
643 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 63,1 |
644 | cord tissue (Wharton's jelly) | choroideremia | ophthalmology | 2016 | experimental therapy | Poland | 50,8 |
645 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 49,3 |
646 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 41,4 |
647 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 33,10 |
648 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 54,8 |
649 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 55,4 |
650 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 4,2 |
651 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 2,10 |
652 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 51,3 |
653 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 56,5 |
654 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 62,8 |
655 | cord tissue (Wharton's jelly) | encephalopathy | neurology | 2016 | experimental therapy | Poland | 2,11 |
656 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 6,10 |
657 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2016 | experimental therapy | Poland | 38 |
658 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 64,2 |
659 | cord tissue (Wharton's jelly) | malformation syndrome | neurology | 2016 | experimental therapy | Poland | 3,5 |
660 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 64,7 |
661 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61,8 |
662 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 56,1 |
663 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 54,3 |
664 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 72,4 |
665 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 46,1 |
666 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55,1 |
667 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 49,7 |
668 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66,2 |
669 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 59, 1 |
670 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 36,1 |
671 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 53,4 |
672 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 45,1 |
673 | cord tissue (Wharton's jelly) | epilepsia | neurology | 2016 | experimental therapy | Poland | 13,11 |
674 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2016 | experimental therapy | Poland | 69,1 |
675 | cord tissue (Wharton's jelly) | optic atrophy | ophthalmology | 2016 | experimental therapy | Poland | 69,9 |
676 | cord tissue (Wharton's jelly) | gonarthrosis | orthopedics | 2016 | experimental therapy | Poland | 49,8 |
677 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 9,11 |
678 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 11,3 |
679 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 6,2 |
680 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2016 | experimental therapy | Poland | 60,5 |
681 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 42,7 |
682 | cord tissue (Wharton's jelly) | epilepsia | neurology | 2016 | experimental therapy | Poland | 14,9 |
683 | cord tissue (Wharton's jelly) | tetraparesis | orthopedics | 2016 | experimental therapy | Poland | 27,9 |
684 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 66,9 |
685 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 59 |
686 | cord tissue (Wharton's jelly) | epilepsia | neurology | 2016 | experimental therapy | Poland | 19,5 |
687 | cord tissue (Wharton's jelly) | traumatic brain injury | neurology | 2016 | experimental therapy | Poland | 54,9 |
688 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 2,9 |
689 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 18,8 |
690 | cord tissue (Wharton's jelly) | tetraparesis spastica | orthopedics | 2016 | experimental therapy | Poland | 47,9 |
691 | cord tissue (Wharton's jelly) | gonarthrosis | orthopedics | 2016 | experimental therapy | Poland | 69,3 |
692 | cord tissue (Wharton's jelly) | spinal muscular atrophy | neurology | 2016 | experimental therapy | Poland | 34,9 |
693 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 60,9 |
694 | cord tissue (Wharton's jelly) | tetraparesis spastica | orthopedics | 2016 | experimental therapy | Poland | 28,8 |
695 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 59,11 |
696 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 52,6 |
697 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 61,7 |
698 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 58,1 |
699 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 55 |
700 | cord tissue (Wharton's jelly) | chronic graft versus host disease | hematology | 2016 | experimental therapy | Poland | 19,2 |
701 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 58 |
702 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 46,9 |
703 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 53,9 |
704 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 54,11 |
705 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 63,2 |
706 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 10,10 |
707 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 25,4 |
708 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 44,8 |
709 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 6,9 |
710 | cord tissue (Wharton's jelly) | patella cartilage damage | orthopedics | 2016 | experimental therapy | Poland | 60,10 |
711 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 39,10 |
712 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 8,5 |
713 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 25,6 |
714 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 24,5 |
715 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 20,7 |
716 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 33,11 |
717 | cord tissue (Wharton's jelly) | gonarthrosis | orthopedics | 2016 | experimental therapy | Poland | 69,6 |
718 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 28 |
719 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 7,11 |
720 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 39,3 |
721 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 37,4 |
722 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 33,4 |
723 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2016 | experimental therapy | Poland | 29,11 |
724 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 8,5 |
725 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 10,3 |
726 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 22,2 |
727 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2016 | experimental therapy | Poland | 33,5 |
728 | cord tissue (Wharton's jelly) | Stargardt's disease | ophthalmology | 2016 | experimental therapy | Poland | 53 |
729 | cord tissue (Wharton's jelly) | atrophy of the optic nerves | ophthalmology | 2016 | experimental therapy | Poland | 20,3 |
730 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 9,7 |
731 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 12,11 |
732 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 2,11 |
733 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 6 |
734 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 59,4 |
735 | cord tissue (Wharton's jelly) | leukodystrophy | neurology | 2016 | experimental therapy | Poland | 2,9 |
736 | cord tissue (Wharton's jelly) | gonarthrosis | orthopedics | 2016 | experimental therapy | Poland | 65,8 |
737 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2016 | experimental therapy | Poland | 6 |
738 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2016 | experimental therapy | Poland | 14 |
739 | cord tissue (Wharton's jelly) | delayed psychomotor development | neurology | 2016 | experimental therapy | Poland | 3,10 |
740 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 12,2 |
741 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 53,7 |
742 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2016 | experimental therapy | Poland | 35,3 |
743 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 10,3 |
744 | cord tissue (Wharton's jelly) | dystrophia progressiva pseudohypertrophica /DMD | neurology | 2016 | experimental therapy | Poland | 48,8 |
745 | cord tissue (Wharton's jelly) | autism | neurology | 2016 | experimental therapy | Poland | 18,4 |
746 | cord tissue (Wharton's jelly) | spinocerebellar ataxia | neurology | 2016 | experimental therapy | Poland | 62,5 |
747 | cord tissue (Wharton's jelly) | spinocerebellar ataxia | neurology | 2016 | experimental therapy | Poland | 64 |
748 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 32,2 |
749 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 60,8 |
750 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2016 | experimental therapy | Poland | 44,5 |
751 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2016 | experimental therapy | Poland | 10,11 |
752 | cord tissue (Wharton's jelly) | adrenoleukodystrophy, encephalopathy | neurology | 2015 | experimental therapy | Poland | 8,4 |
753 | cord tissue (Wharton's jelly) | encephalopathy | neurology | 2015 | experimental therapy | Poland | 11,2 |
754 | cord tissue (Wharton's jelly) | cerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 26,1 |
755 | cord tissue (Wharton's jelly) | retinitis pigmentosa | ophthalmology | 2015 | experimental therapy | Poland | 34,5 |
756 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 16,9 |
757 | cord tissue (Wharton's jelly) | anterior ischemic optic neuropathy | ophthalmology | 2015 | experimental therapy | Poland | 54,10 |
758 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 14,10 |
759 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 1,6 |
760 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 34,4 |
761 | cord tissue (Wharton's jelly) | leukodystrophy | neurology | 2015 | experimental therapy | Poland | 18,8 |
762 | cord tissue (Wharton's jelly) | gonarthrosis | orthopedics | 2015 | experimental therapy | Poland | 65,9 |
763 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 24,7 |
764 | cord tissue (Wharton's jelly) | stroke | neurology | 2015 | experimental therapy | Poland | 54,9 |
765 | cord tissue (Wharton's jelly) | intracranial injury | neurology | 2015 | experimental therapy | Poland | 24,3 |
766 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 54 |
767 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61,3 |
768 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 13,4 |
769 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 9,9 |
770 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 21,4 |
771 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 48,7 |
772 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 6,6 |
773 | cord tissue (Wharton's jelly) | encephalopathy | neurology | 2015 | experimental therapy | Poland | 8/12 |
774 | cord tissue (Wharton's jelly) | autism | neurology | 2015 | experimental therapy | Poland | 8,7 |
775 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 46,2 |
776 | cord tissue (Wharton's jelly) | spinal muscular atrophy | neurology | 2015 | experimental therapy | Poland | 26,2 |
777 | cord tissue (Wharton's jelly) | severe developmental delay | neurology | 2015 | experimental therapy | Poland | 1,1 |
778 | cord tissue (Wharton's jelly) | chronic graft versus host disease | hematology | 2015 | experimental therapy | Poland | 10 |
779 | cord tissue (Wharton's jelly) | facio-scapulo-humeral muscular dystrophy | neurology | 2015 | experimental therapy | Poland | 30,1 |
780 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 58,10 |
781 | cord tissue (Wharton's jelly) | stroke | neurology | 2015 | experimental therapy | Poland | 62,8 |
782 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 37,6 |
783 | cord tissue (Wharton's jelly) | polineuropathy | neurology | 2015 | experimental therapy | Poland | 74,2 |
784 | cord tissue (Wharton's jelly) | autism | neurology | 2015 | experimental therapy | Poland | 5,6 |
785 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 67,6 |
786 | cord tissue (Wharton's jelly) | spinocerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 24,3 |
787 | cord tissue (Wharton's jelly) | cerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 18,7 |
788 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2015 | experimental therapy | Poland | 2 |
789 | cord tissue (Wharton's jelly) | delayed psychomotor development | neurology | 2015 | experimental therapy | Poland | 3,6 |
790 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2015 | experimental therapy | Poland | 33,3 |
791 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 22 |
792 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 32,10 |
793 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 63,11 |
794 | cord tissue (Wharton's jelly) | autism | neurology | 2015 | experimental therapy | Poland | 4,6 |
795 | cord tissue (Wharton's jelly) | autism | neurology | 2015 | experimental therapy | Poland | 6,1 |
796 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 4,10 |
797 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 27 |
798 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 26,5 |
799 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 12,10 |
800 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 51,5 |
801 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 62 |
802 | cord tissue (Wharton's jelly) | optic neuropathy | ophthalmology | 2015 | experimental therapy | Poland | 45,10 |
803 | cord tissue (Wharton's jelly) | iatrogenic spinal cord injury | neurology | 2015 | experimental therapy | Poland | 17,2 |
804 | cord tissue (Wharton's jelly) | gonarthrosis | orthopedics | 2015 | experimental therapy | Poland | 66,2 |
805 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61,6 |
806 | cord tissue (Wharton's jelly) | optic neuropathy | ophthalmology | 2015 | experimental therapy | Poland | 15,8 |
807 | cord tissue (Wharton's jelly) | spinocerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 44,6 |
808 | cord tissue (Wharton's jelly) | spinal muscular atrophy | neurology | 2015 | experimental therapy | Poland | 11/12 |
809 | cord tissue (Wharton's jelly) | spinocerebellar ataxia | neurology | 2015 | experimental therapy | Poland | 35,6 |
810 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 58 |
811 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 37,1 |
812 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 26,1 |
813 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 40 |
814 | cord tissue (Wharton's jelly) | adrenoleukodystrophy | neurology | 2015 | experimental therapy | Poland | 11,11 |
815 | cord tissue (Wharton's jelly) | adrenoleukodystrophy, encephalopathy | neurology | 2015 | experimental therapy | Poland | 23 |
816 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 2,7 |
817 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 18,8 |
818 | cord tissue (Wharton's jelly) | traumatic encephalopathy | neurology | 2015 | experimental therapy | Poland | 20,11 |
819 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61,5 |
820 | cord tissue (Wharton's jelly) | delayed psychomotor development, deafness | neurology | 2015 | experimental therapy | Poland | 3,3 |
821 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 8,11 |
822 | cord tissue (Wharton's jelly) | autism | neurology | 2015 | experimental therapy | Poland | 12,5 |
823 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 5,1 |
824 | cord tissue (Wharton's jelly) | spinal cord injury | orthopedics | 2015 | experimental therapy | Poland | 31,2 |
825 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 59,4 |
826 | cord tissue (Wharton's jelly) | spina bifida | neurology | 2015 | experimental therapy | Poland | 2,4 |
827 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 13,1 |
828 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 7,1 |
829 | cord tissue (Wharton's jelly) | autism | neurology | 2015 | experimental therapy | Poland | 3 |
830 | cord tissue (Wharton's jelly) | ceroid lipofuscinosis | neurology | 2015 | experimental therapy | Poland | 7,10 |
831 | cord tissue (Wharton's jelly) | encephalopathy | neurology | 2015 | experimental therapy | Poland | 14,5 |
832 | cord tissue (Wharton's jelly) | ceroid lipofuscinosis | neurology | 2015 | experimental therapy | Poland | 5,1 |
833 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 15,8 |
834 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 7,1 |
835 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 11/12 |
836 | cord tissue (Wharton's jelly) | bilateral blindness | ophthalmology | 2015 | experimental therapy | Poland | 36,10 |
837 | cord tissue (Wharton's jelly) | decerebration rigidity | neurology | 2015 | experimental therapy | Poland | 9,6 |
838 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2015 | experimental therapy | Poland | 3,8 |
839 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 52 |
840 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 60 |
841 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 65 |
842 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 51 |
843 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 56 |
844 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61 |
845 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2015 | experimental therapy | Poland | 61,6 |
846 | cord tissue (Wharton's jelly) | sclerosis multiplex | neurology | 2015 | experimental therapy | Poland | 23,2 |
847 | cord tissue (Wharton's jelly) | autism | neurology | 2015 | experimental therapy | Poland | 5,4 |
848 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2015 | experimental therapy | Poland | 1,4 |
849 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2014 | experimental therapy | Poland | 15,10 |
850 | cord tissue (Wharton's jelly) | cerebral palsy | neurology | 2014 | experimental therapy | Poland | 4,10 |
851 | cord tissue (Wharton's jelly) | birth asphyxia, retinopathy | neurology | 2014 | experimental therapy | Poland | 11/12 |
852 | cord tissue (Wharton's jelly) | muscular dystrophy | neurology | 2014 | experimental therapy | Poland | 6 |
853 | cord tissue (Wharton's jelly) | autism | neurology | 2014 | experimental therapy | Poland | 8,3 |
854 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2014 | experimental therapy | Poland | 24,1 |
855 | cord tissue (Wharton's jelly) | amyotrophic lateral sclerosis | neurology | 2014 | experimental therapy | Poland | 60,10 |
856 | cord tissue (Wharton's jelly) | central motor coordination impairment after hypoxic ischaemia lesion at birth | neurology | 2014 | experimental therapy | Poland | 2,1 |
857 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2014 | experimental therapy | Poland | 6 |
858 | cord tissue (Wharton's jelly) | autism | neurology | 2014 | experimental therapy | Poland | 12,6 |
859 | cord tissue (Wharton's jelly) | neuropathy | neurology | 2014 | experimental therapy | Poland | 23,6 |
860 | cord tissue (Wharton's jelly) | chronic graft versus host disease | hematology | 2013 | experimental therapy | Poland | 17,5 |
861 | cord tissue (Wharton's jelly) | chronic graft versus host disease | hematology | 2013 | experimental therapy | Poland | 18,8 |
862 | cord tissue (Wharton's jelly) | acute myeloid leukemia | hematology | 2013 | experimental therapy | Poland | 3,5 |
863 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2013 | experimental therapy | Poland | 3,5 |
864 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2013 | experimental therapy | Poland | 2,11 |
865 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2013 | experimental therapy | Poland | 18,9 |
866 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2012 | experimental therapy | Poland | 4,3 |
867 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2012 | experimental therapy | Poland | 7,1 |
868 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2012 | experimental therapy | Poland | 19,7 |
869 | cord tissue (Wharton's jelly) | acute graft versus host disease | hematology | 2011 | experimental therapy | Poland | 17,2 |
870 | bone marrow | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Argentina | 14 |
871 | bone marrow | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 11 |
872 | bone marrow | severe aplastic anaemia | hematology | 2018 | standard therapy | Italy | 14 |
873 | bone marrow | severe combined immunodeficiency | hematology | 2018 | standard therapy | Israel | 2 |
874 | bone marrow | diffuse large B-cell lymphoma | hematology | 2018 | standard therapy | Germany | 68 |
875 | bone marrow | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 50 |
876 | bone marrow | severe aplastic anaemia | hematology | 2018 | standard therapy | USA | 19 |
877 | bone marrow | thalassemia major | hematology | 2018 | standard therapy | Sweden | 14 |
878 | bone marrow | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 36 |
879 | bone marrow | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 12 |
880 | bone marrow | no data | hematology | 2018 | standard therapy | Germany | 16 |
881 | bone marrow | no data | hematology | 2018 | standard therapy | Spain | 48 |
882 | bone marrow | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Brazil | 3 |
883 | bone marrow | acute myelogenous leukemia | hematology | 2018 | standard therapy | Switzerland | 67 |
884 | bone marrow | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 3/4 |
885 | bone marrow | bilineal leukemia -acute lymphoblastic leukemia, acute myelogenous leukemia | hematology | 2018 | standard therapy | Belarus | 2 |
886 | bone marrow | Hodgkin’s lymphoma | hematology | 2018 | standard therapy | USA | 31 |
887 | bone marrow | juvenile myelomonocytic leukemia | hematology | 2018 | standard therapy | Hungary | 11 |
888 | bone marrow | chronic granulomatous disease | hematology | 2018 | standard therapy | Switzerland | 3 |
889 | bone marrow | myelodysplastic syndrome | hematology | 2018 | standard therapy | Italy | 4 |
890 | bone marrow | primary Immunodeficiency, Nijmegen breakage syndrome | hematology | 2017 | standard therapy | Belarus | 6 |
891 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 19 |
892 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Hungary | 7 |
893 | bone marrow | Fanconi anaemia | hematology | 2017 | standard therapy | Belarus | 10 |
894 | bone marrow | severe combined immunodeficiency | hematology | 2017 | standard therapy | Turkey | 8 |
895 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 2 |
896 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 18 |
897 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | India | 7 |
898 | bone marrow | secondary acute myelogenous leukemia after Ewing sarcoma | hematology | 2017 | standard therapy | Germany | 16 |
899 | bone marrow | Nijmegen breakage syndrome | hematology | 2017 | standard therapy | Poland | 8 |
900 | bone marrow | myelodysplastic syndrome | hematology | 2017 | standard therapy | Norway | 2 |
901 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 12 |
902 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 2 |
903 | bone marrow | other combined immunodeficiency | hematology | 2017 | standard therapy | USA | 11 |
904 | bone marrow | myeloma multiplex | hematology | 2017 | standard therapy | Canada | 50 |
905 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 7 |
906 | bone marrow | T-cell leukemia/lymphoma | hematology | 2017 | standard therapy | Iran | 18 |
907 | bone marrow | Wiskott-Aldrich syndrome | hematology | 2017 | standard therapy | Iran | 2 |
908 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 4 |
909 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Brazil | 14 |
910 | bone marrow | no data | hematology | 2017 | standard therapy | France | 32 |
911 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 9 |
912 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | United Kingdom | 8 |
913 | bone marrow | severe combined immunodeficiency | hematology | 2017 | standard therapy | Poland | 1 |
914 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 24 |
915 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 54 |
916 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 56 |
917 | bone marrow | chronic myeloid leukemia | hematology | 2017 | standard therapy | USA | 51 |
918 | bone marrow | acute megakaryocytic leukemia | hematology | 2017 | standard therapy | Spain | 2 |
919 | bone marrow | juvenile myelomonocytic leukemia | hematology | 2017 | standard therapy | Finland | 1 |
920 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 51 |
921 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 17 |
922 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 10 |
923 | bone marrow | Fanconi anaemia | hematology | 2017 | standard therapy | Russia | 10 |
924 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 60 |
925 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Czech Republic | 68 |
926 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 10 |
927 | bone marrow | thalassemia major | hematology | 2017 | standard therapy | Turkey | 11 |
928 | bone marrow | pure red cell aplasia | hematology | 2017 | standard therapy | USA | 5 |
929 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 57 |
930 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 59 |
931 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 1 |
932 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Austria | 3 |
933 | bone marrow | hyper IgM syndrome | hematology | 2017 | standard therapy | Finland | 2 |
934 | bone marrow | severe combined immunodeficiency | hematology | 2017 | standard therapy | Turkey | 2 |
935 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 21 |
936 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 59 |
937 | bone marrow | severe combined immunodeficiency | hematology | 2017 | standard therapy | Canada | 1 |
938 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | United Kingdom | 9 |
939 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 38 |
940 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 13 |
941 | bone marrow | severe combined immunodeficiency | hematology | 2017 | standard therapy | Lithuania | 1 |
942 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 16 |
943 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 67 |
944 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 55 |
945 | bone marrow | severe combined immunodeficiency | hematology | 2017 | standard therapy | Turkey | 6 |
946 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Hungary | 14 |
947 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | United Kingdom | 10 |
948 | bone marrow | leukemia | hematology | 2017 | standard therapy | USA | 40 |
949 | bone marrow | chronic granulomatous disease | hematology | 2017 | standard therapy | Poland | 4 |
950 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Russia | 30 |
951 | bone marrow | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 61 |
952 | bone marrow | myelodysplastic syndrome | hematology | 2017 | standard therapy | Italy | 60 |
953 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 65 |
954 | bone marrow | chronic granulomatous disease | hematology | 2017 | standard therapy | Poland | 2 |
955 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Turkey | 22 |
956 | bone marrow | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 76 |
957 | bone marrow | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 6 |
958 | bone marrow | high-risk acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 18 |
959 | bone marrow | anaemia | hematology | 2016 | standard therapy | Italy | 5 |
960 | bone marrow | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 6 |
961 | bone marrow | anaemia | hematology | 2016 | standard therapy | Germany | 16 |
962 | bone marrow | acute myelogenous leukemia | hematology | 2016 | standard therapy | Finland | 45 |
963 | bone marrow | juvenile myelomonocytic leukemia | hematology | 2016 | standard therapy | Germany | 3 |
964 | bone marrow | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Belarus | 15 |
965 | bone marrow | acute myelogenous leukemia | hematology | 2016 | standard therapy | Czech Republic | 9 |
966 | bone marrow | Diamond-Balckfan anaemia | hematology | 2016 | standard therapy | Germany | 2 |
967 | bone marrow | acute myelogenous leukemia | hematology | 2016 | standard therapy | Ireland | 39 |
968 | bone marrow | myeloproliferative syndrome | hematology | 2016 | standard therapy | Poland | 22 |
969 | bone marrow | acute myelogenous leukemia | hematology | 2016 | standard therapy | Croatia | 33 |
970 | bone marrow | aplastic anaemia | hematology | 2016 | standard therapy | Austria | 20 |
971 | bone marrow | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Italy | 46 |
972 | bone marrow | no data | n/a | 2016 | standard therapy | Poland | 33 |
973 | bone marrow | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 5 |
974 | bone marrow | severe combined immunodeficiency | hematology | 2016 | standard therapy | Germany | 12 |
975 | bone marrow | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | New Zealand | 1 |
976 | bone marrow | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Belarus | 25 |
977 | bone marrow | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 29 |
978 | bone marrow | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 5 |
979 | bone marrow | Fanconi anaemia | hematology | 2016 | standard therapy | Netherlands | 41 |
980 | bone marrow | myelodysplastic syndrome | hematology | 2016 | standard therapy | Spain | 56 |
981 | bone marrow | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 67 |
982 | bone marrow | myelodysplastic syndrome | hematology | 2016 | standard therapy | Hungary | 1 |
983 | bone marrow | severe aplastic anaemia / paroxymal nocturnal haemoglobinuria | hematology | 2016 | standard therapy | Poland | 17 |
984 | bone marrow | severe aplastic anaemia | hematology | 2016 | standard therapy | France | 9 |
985 | bone marrow | severe combined immunodeficiency | hematology | 2016 | standard therapy | Poland | 7/12 |
986 | bone marrow | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Belarus | 18 |
987 | bone marrow | acute myelogenous leukemia | hematology | 2016 | standard therapy | Belarus | 12 |
988 | bone marrow | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Italy | 17 |
989 | bone marrow | DiGeorge syndrome | hematology | 2016 | standard therapy | Netherlands | 24 |
990 | bone marrow | myelofibrosis | hematology | 2016 | standard therapy | Germany | 31 |
991 | bone marrow | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Canada | 11 |
992 | bone marrow | severe combined immunodeficiency | hematology | 2016 | standard therapy | Turkey | 4 |
993 | bone marrow | Hurler syndrome | metabolic | 2016 | standard therapy | United Kingdom | 2 |
994 | bone marrow | no data | n/a | 2016 | standard therapy | Poland | 7 |
995 | bone marrow | severe aplastic anaemia | hematology | 2016 | standard therapy | France | 9 |
996 | bone marrow | osteopetrosis | metabolic | 2016 | standard therapy | Germany | 1 |
997 | bone marrow | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 7 |
998 | bone marrow | biphenotypic leukemia | hematology | 2016 | standard therapy | Brazil | 27 |
999 | bone marrow | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 14 |
1000 | bone marrow | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 64 |
1001 | bone marrow | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 6 |
1002 | bone marrow | Fanconi anaemia | hematology | 2016 | standard therapy | Estonia | 7 |
1003 | bone marrow | acute myelogenous leukemia | hematology | 2016 | standard therapy | Spain | 55 |
1004 | bone marrow | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 9 |
1005 | bone marrow | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 64 |
1006 | bone marrow | no data | n/a | 2016 | standard therapy | Italy | 3 |
1007 | bone marrow | T-cell acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 4 |
1008 | bone marrow | severe combined immunodeficiency | hematology | 2016 | standard therapy | Romania | 2 |
1009 | bone marrow | osteopetrosis | metabolic | 2016 | standard therapy | Russia | 6 |
1010 | peripheral blood | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 50 |
1011 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 76 |
1012 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 46 |
1013 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 61 |
1014 | peripheral blood | myeloma multiplex | hematology | 2018 | standard therapy | USA | 57 |
1015 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 64 |
1016 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Slovenia | 54 |
1017 | peripheral blood | myelodysplastic syndrome | hematology | 2018 | standard therapy | United Kingdom | 22 |
1018 | peripheral blood | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 67 |
1019 | peripheral blood | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 54 |
1020 | peripheral blood | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 8 |
1021 | peripheral blood | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 62 |
1022 | peripheral blood | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 68 |
1023 | peripheral blood | T-cell acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 13 |
1024 | peripheral blood | B-cell Acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 41 |
1025 | peripheral blood | myelodysplastic syndrome | hematology | 2018 | standard therapy | Italy | 62 |
1026 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 64 |
1027 | peripheral blood | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 47 |
1028 | peripheral blood | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 50 |
1029 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 61 |
1030 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 64 |
1031 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 51 |
1032 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 61 |
1033 | peripheral blood | myelodysplastic syndrome | hematology | 2018 | standard therapy | Poland | 59 |
1034 | peripheral blood | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 72 |
1035 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 54 |
1036 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 56 |
1037 | peripheral blood | myelodysplastic syndrome | hematology | 2018 | standard therapy | Netherlands | 67 |
1038 | peripheral blood | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 42 |
1039 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 71 |
1040 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 30 |
1041 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Italy | 67 |
1042 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 45 |
1043 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 45 |
1044 | peripheral blood | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 61 |
1045 | peripheral blood | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | France | 33 |
1046 | peripheral blood | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | France | 50 |
1047 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 72 |
1048 | peripheral blood | myelofibrosis | hematology | 2018 | standard therapy | Germany | 60 |
1049 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Spain | 34 |
1050 | peripheral blood | Hodgkin’s lymphoma | hematology | 2018 | standard therapy | Poland | 38 |
1051 | peripheral blood | acute myeloid leukemia in first complete remission | hematology | 2018 | standard therapy | Germany | 61 |
1052 | peripheral blood | Secondary AML MLL(+), High risk CR1 | hematology | 2018 | standard therapy | Poland | 58 |
1053 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | France | 46 |
1054 | peripheral blood | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Poland | 48 |
1055 | peripheral blood | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Italy | 65 |
1056 | peripheral blood | other myleofibrosis | hematology | 2018 | standard therapy | Poland | 57 |
1057 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Poland | 66 |
1058 | peripheral blood | non-Hodgkin lymphoma | hematology | 2018 | standard therapy | Poland | 23 |
1059 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 46 |
1060 | peripheral blood | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | USA | 63 |
1061 | peripheral blood | myeloma multiplex | hematology | 2018 | standard therapy | Lithuania | 56 |
1062 | peripheral blood | T-cell acute lymphoblastic leukemia | hematology | 2018 | standard therapy | Germany | 7 |
1063 | peripheral blood | severe aplastic anaemia | hematology | 2018 | standard therapy | Germany | 18 |
1064 | peripheral blood | myelodysplastic syndrome | hematology | 2018 | standard therapy | USA | 74 |
1065 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | United Kingdom | 42 |
1066 | peripheral blood | acute lymphoblastic leukemia | hematology | 2018 | standard therapy | United Kingdom | 29 |
1067 | peripheral blood | myelofibrosis | hematology | 2018 | standard therapy | Netherlands | 49 |
1068 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Canada | 59 |
1069 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | Germany | 35 |
1070 | peripheral blood | acute myelogenous leukemia | hematology | 2018 | standard therapy | USA | 26 |
1071 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 13 |
1072 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 71 |
1073 | peripheral blood | no data | hematology | 2017 | standard therapy | Switzerland | 68 |
1074 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 8 |
1075 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 37 |
1076 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Belgium | 26 |
1077 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 10 |
1078 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 70 |
1079 | peripheral blood | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | Germany | 60 |
1080 | peripheral blood | myelodysplastic syndrome in Fanconi anaemia | hematology | 2017 | standard therapy | Italy | 23 |
1081 | peripheral blood | chronic myeloid leukemia | hematology | 2017 | standard therapy | USA | 57 |
1082 | peripheral blood | Hodgkin’s lymphoma | hematology | 2017 | standard therapy | USA | 25 |
1083 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 72 |
1084 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | United Kingdom | 24 |
1085 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 63 |
1086 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 72 |
1087 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 69 |
1088 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 57 |
1089 | peripheral blood | myeloma multiplex | hematology | 2017 | standard therapy | Poland | 38 |
1090 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 27 |
1091 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 69 |
1092 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 40 |
1093 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Canada | 22 |
1094 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 61 |
1095 | peripheral blood | myeloma multiplex | hematology | 2017 | standard therapy | USA | 57 |
1096 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 64 |
1097 | peripheral blood | no data | hematology | 2017 | standard therapy | Canada | 55 |
1098 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | France | 61 |
1099 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 58 |
1100 | peripheral blood | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | Germany | 72 |
1101 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 53 |
1102 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 71 |
1103 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 55 |
1104 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 68 |
1105 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 46 |
1106 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Turkey | 26 |
1107 | peripheral blood | secondary acute myelogenous leukemia | hematology | 2017 | standard therapy | Austria | 24 |
1108 | peripheral blood | severe aplastic anaemia | hematology | 2017 | standard therapy | Russia | 16 |
1109 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Israel | 6 |
1110 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 23 |
1111 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Israel | 37 |
1112 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 63 |
1113 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Sweden | 59 |
1114 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 50 |
1115 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 63 |
1116 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 68 |
1117 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Netherlands | 65 |
1118 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 55 |
1119 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 67 |
1120 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 66 |
1121 | peripheral blood | no data | hematology | 2017 | standard therapy | Poland | 1 |
1122 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Sweden | 69 |
1123 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 53 |
1124 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 66 |
1125 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 52 |
1126 | peripheral blood | blastic plasmacytoid,dendritic cell neoplasm | hematology | 2017 | standard therapy | Germany | 56 |
1127 | peripheral blood | myelofibrosis | hematology | 2017 | standard therapy | USA | 47 |
1128 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 62 |
1129 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 24 |
1130 | peripheral blood | primary myelofibrosis | hematology | 2017 | standard therapy | Poland | 32 |
1131 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Netherlands | 71 |
1132 | peripheral blood | B-cell Acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Germany | 64 |
1133 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 21 |
1134 | peripheral blood | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | Germany | 7 |
1135 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 57 |
1136 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 63 |
1137 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Australia | 43 |
1138 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Norway | 56 |
1139 | peripheral blood | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | USA | 51 |
1140 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Belgium | 69 |
1141 | peripheral blood | myelofibrosis | hematology | 2017 | standard therapy | Netherlands | 72 |
1142 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | France | 36 |
1143 | peripheral blood | B-cell Acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Spain | 28 |
1144 | peripheral blood | T-cell acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Greece | 28 |
1145 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 17 |
1146 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 16 |
1147 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 53 |
1148 | peripheral blood | prolymphocytic leukemia | hematology | 2017 | standard therapy | Poland | 63 |
1149 | peripheral blood | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | Italy | 61 |
1150 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 63 |
1151 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 59 |
1152 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 62 |
1153 | peripheral blood | primary myelofibrosis | hematology | 2017 | standard therapy | Germany | 29 |
1154 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Canada | 46 |
1155 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 62 |
1156 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 56 |
1157 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 68 |
1158 | peripheral blood | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | United Kingdom | 51 |
1159 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Finland | 58 |
1160 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Netherlands | 53 |
1161 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Hungary | 40 |
1162 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 61 |
1163 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 54 |
1164 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Italy | 57 |
1165 | peripheral blood | other malignancy | hematology | 2017 | standard therapy | France | 59 |
1166 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Lithuania | 53 |
1167 | peripheral blood | B-cell Acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Germany | 44 |
1168 | peripheral blood | severe aplastic anaemia | hematology | 2017 | standard therapy | Poland | 32 |
1169 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 22 |
1170 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 53 |
1171 | peripheral blood | severe aplastic anaemia | hematology | 2017 | standard therapy | Poland | 27 |
1172 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 49 |
1173 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 60 |
1174 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 64 |
1175 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 31 |
1176 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 57 |
1177 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 30 |
1178 | peripheral blood | chronic myeloid leukemia | hematology | 2017 | standard therapy | USA | 74 |
1179 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Poland | 52 |
1180 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Germany | 64 |
1181 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Belgium | 70 |
1182 | peripheral blood | no data | hematology | 2017 | standard therapy | Poland | 53 |
1183 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 35 |
1184 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 51 |
1185 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 65 |
1186 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 60 |
1187 | peripheral blood | primary Immunodeficiency | hematology | 2017 | standard therapy | Russia | 2 |
1188 | peripheral blood | myelofibrosis | hematology | 2017 | standard therapy | USA | 62 |
1189 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 49 |
1190 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Canada | 41 |
1191 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 52 |
1192 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 76 |
1193 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 68 |
1194 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Canada | 55 |
1195 | peripheral blood | T-cell acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Australia | 25 |
1196 | peripheral blood | no data | hematology | 2017 | standard therapy | Poland | 58 |
1197 | peripheral blood | myeloproliferative neoplasms | hematology | 2017 | standard therapy | Poland | 7 |
1198 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 42 |
1199 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Canada | 4 |
1200 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Israel | 11 |
1201 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Amsterdam | 69 |
1202 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 68 |
1203 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 43 |
1204 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Switzerland | 67 |
1205 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 19 |
1206 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 69 |
1207 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Netherlands | 51 |
1208 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 58 |
1209 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 67 |
1210 | peripheral blood | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | USA | 58 |
1211 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 65 |
1212 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 62 |
1213 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | France | 39 |
1214 | peripheral blood | primary Immunodeficiency | hematology | 2017 | standard therapy | Russia | 4 |
1215 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | France | 63 |
1216 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 63 |
1217 | peripheral blood | no data | hematology | 2017 | standard therapy | Kanada | 32 |
1218 | peripheral blood | myelofibrosis | hematology | 2017 | standard therapy | USA | 62 |
1219 | peripheral blood | T-cell acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 7 |
1220 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Poland | 36 |
1221 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Hungary | 32 |
1222 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 38 |
1223 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 38 |
1224 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 49 |
1225 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 60 |
1226 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Netherlands | 51 |
1227 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Turkey | 54 |
1228 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Turkey | 58 |
1229 | peripheral blood | no data | hematology | 2017 | standard therapy | Russia | 36 |
1230 | peripheral blood | chronic granulomatous disease | hematology | 2017 | standard therapy | Poland | 4 |
1231 | peripheral blood | no data | hematology | 2017 | standard therapy | Germany | 65 |
1232 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 29 |
1233 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Czech Republic | 12 |
1234 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 63 |
1235 | peripheral blood | myelofibrosis | hematology | 2017 | standard therapy | Germany | 29 |
1236 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Finland | 46 |
1237 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 35 |
1238 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Slovakia | 54 |
1239 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 23 |
1240 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | France | 65 |
1241 | peripheral blood | prolymphocytic leukemia | hematology | 2017 | standard therapy | Belgium | 38 |
1242 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 54 |
1243 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 39 |
1244 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 69 |
1245 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 64 |
1246 | peripheral blood | other myleofibrosis | hematology | 2017 | standard therapy | USA | 71 |
1247 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 35 |
1248 | peripheral blood | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | USA | 65 |
1249 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Canada | 63 |
1250 | peripheral blood | follicular CA | hematology | 2017 | standard therapy | South Africa | 42 |
1251 | peripheral blood | acute myelogenous leukemia with myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 64 |
1252 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Czech Republic | 62 |
1253 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 55 |
1254 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 53 |
1255 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Czech Republic | 48 |
1256 | peripheral blood | β - Thalassemia Major | hematology | 2017 | standard therapy | India | 4 |
1257 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 67 |
1258 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Canada | 67 |
1259 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Poland | 59 |
1260 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 62 |
1261 | peripheral blood | myelofibrosis | hematology | 2017 | standard therapy | United Kingdom | 55 |
1262 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 59 |
1263 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 52 |
1264 | peripheral blood | myeloproliferative neoplasms | hematology | 2017 | standard therapy | Poland | 7 |
1265 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 68 |
1266 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Belgium | 34 |
1267 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 70 |
1268 | peripheral blood | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | Estonia | 67 |
1269 | peripheral blood | T-cell acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Australia | 30 |
1270 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 51 |
1271 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 69 |
1272 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Switzerland | 75 |
1273 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Lithuania | 65 |
1274 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Canada | 56 |
1275 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 55 |
1276 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 56 |
1277 | peripheral blood | osteopetrosis | hematology | 2017 | standard therapy | Israel | 3 |
1278 | peripheral blood | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | Poland | 47 |
1279 | peripheral blood | B-cell Chronic lymphoblastic leukemia | hematology | 2017 | standard therapy | Germany | 48 |
1280 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 65 |
1281 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Germany | 56 |
1282 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 64 |
1283 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 33 |
1284 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 67 |
1285 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 53 |
1286 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Australia | 60 |
1287 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 63 |
1288 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 42 |
1289 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 75 |
1290 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 32 |
1291 | peripheral blood | chronic myelomonocytic leukaemia | hematology | 2017 | standard therapy | Germany | 54 |
1292 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Italy | 58 |
1293 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Canada | 57 |
1294 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Germany | 50 |
1295 | peripheral blood | myelofibrosis | hematology | 2017 | standard therapy | USA | 62 |
1296 | peripheral blood | aplastic anaemia | hematology | 2017 | standard therapy | United Kingdom | 23 |
1297 | peripheral blood | no data | hematology | 2017 | standard therapy | Poland | 39 |
1298 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Belgium | 55 |
1299 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Turkey | 46 |
1300 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Belgium | 71 |
1301 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 64 |
1302 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 65 |
1303 | peripheral blood | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | USA | 45 |
1304 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Belgium | 19 |
1305 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Norway | 57 |
1306 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Brazil | 12 |
1307 | peripheral blood | hemophagocytosis | hematology | 2017 | standard therapy | USA | 52 |
1308 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 45 |
1309 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Lithuania | 59 |
1310 | peripheral blood | myeloma multiplex | hematology | 2017 | standard therapy | Germany | 56 |
1311 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 60 |
1312 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Sweden | 63 |
1313 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 61 |
1314 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Netherlands | 75 |
1315 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Netherlands | 66 |
1316 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 53 |
1317 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Poland | 46 |
1318 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | USA | 44 |
1319 | peripheral blood | myelofibrosis | hematology | 2017 | standard therapy | Germany | 66 |
1320 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Croatia | 64 |
1321 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Spain | 20 |
1322 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 3 |
1323 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | Italy | 47 |
1324 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | France | 56 |
1325 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 48 |
1326 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | France | 43 |
1327 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Germany | 47 |
1328 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 53 |
1329 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Russia | 32 |
1330 | peripheral blood | chronic lymphocytic leukemia | hematology | 2017 | standard therapy | Belgium | 57 |
1331 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Slovakia | 64 |
1332 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 75 |
1333 | peripheral blood | Langerhans Lymphohistiocytosis | hematology | 2017 | standard therapy | Czech Republic | 2 |
1334 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Poland | 54 |
1335 | peripheral blood | no data | n/a | 2017 | standard therapy | France | 39 |
1336 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Hungary | 47 |
1337 | peripheral blood | myelofibrosis | hematology | 2017 | standard therapy | Denmark | 63 |
1338 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Austria | 54 |
1339 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | Italy | 48 |
1340 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | USA | 56 |
1341 | peripheral blood | diffuse large B-cell lymphoma | hematology | 2017 | standard therapy | Germany | 61 |
1342 | peripheral blood | myelofibrosis | hematology | 2017 | standard therapy | Spain | 63 |
1343 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | France | 65 |
1344 | peripheral blood | Common variable immunodeficiency, relapsed hemophagocytic syndrome | hematology | 2017 | standard therapy | Germany | 44 |
1345 | peripheral blood | non-Hodgkin lymphoma | hematology | 2017 | standard therapy | USA | 63 |
1346 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Poland | 3 |
1347 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Iran | 17 |
1348 | peripheral blood | Niemann–Pick disease | hematology | 2017 | standard therapy | Poland | 2 |
1349 | peripheral blood | severe aplastic anaemia | hematology | 2017 | standard therapy | Poland | 14 |
1350 | peripheral blood | chronic myeloid leukemia | hematology | 2017 | standard therapy | Turkey | 29 |
1351 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | France | 68 |
1352 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | Poland | 43 |
1353 | peripheral blood | chronic myeloproliferative neoplasm blast crisis | hematology | 2017 | standard therapy | Germany | 29 |
1354 | peripheral blood | acute myelogenous leukemia | hematology | 2017 | standard therapy | United Kingdom | 51 |
1355 | peripheral blood | acute lymphoblastic leukemia | hematology | 2017 | standard therapy | USA | 24 |
1356 | peripheral blood | myelodysplastic syndrome | hematology | 2017 | standard therapy | Poland | 60 |
1357 | peripheral blood | myeloma multiplex | hematology | 2017 | standard therapy | Germany | 44 |
1358 | peripheral blood | Hurler syndrome | hematology | 2017 | standard therapy | United Kingdom | 2 |
1359 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 66 |
1360 | peripheral blood | severe aplastic anaemia | hematology | 2016 | standard therapy | Russia | 18 |
1361 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 35 |
1362 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | USA | 69 |
1363 | peripheral blood | T-cell-prolymphocytic leukemia | hematology | 2016 | standard therapy | United Kingdom | 61 |
1364 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 19 |
1365 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 63 |
1366 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 62 |
1367 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 67 |
1368 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Canada | 47 |
1369 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 47 |
1370 | peripheral blood | plasma cell disorder | hematology | 2016 | standard therapy | France | 54 |
1371 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Spain | 50 |
1372 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 21 |
1373 | peripheral blood | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Netherlands | 39 |
1374 | peripheral blood | acute myelogenous leukemia M2/M4 | hematology | 2016 | standard therapy | Germany | 59 |
1375 | peripheral blood | high-risk acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 5 |
1376 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Italy | 58 |
1377 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 33 |
1378 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 30 |
1379 | peripheral blood | composite lymphoma | hematology | 2016 | standard therapy | Germany | 51 |
1380 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 55 |
1381 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 62 |
1382 | peripheral blood | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Russia | 32 |
1383 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 59 |
1384 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Russia | 44 |
1385 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 37 |
1386 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 15 |
1387 | peripheral blood | chronic myeloid leukemia | hematology | 2016 | standard therapy | Germany | 40 |
1388 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Greece | 9 |
1389 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 24 |
1390 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 54 |
1391 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 56 |
1392 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 63 |
1393 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 68 |
1394 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 72 |
1395 | peripheral blood | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Poland | 58 |
1396 | peripheral blood | B-cell Acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Belgium | 44 |
1397 | peripheral blood | myelofibrosis | hematology | 2016 | standard therapy | France | 67 |
1398 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 20 |
1399 | peripheral blood | non-Hodgkin lymphoma | hematology | 2016 | standard therapy | Russia | 38 |
1400 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Italy | 66 |
1401 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 50 |
1402 | peripheral blood | chronic myeloid leukemia | hematology | 2016 | standard therapy | Finland | 46 |
1403 | peripheral blood | SAA / Amyloidosis | hematology | 2016 | standard therapy | United Kingdom | 45 |
1404 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | France | 59 |
1405 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Portugal | 41 |
1406 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 65 |
1407 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Australia | 62 |
1408 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | New Zealand | 59 |
1409 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Austria | 61 |
1410 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 39 |
1411 | peripheral blood | myeloma multiplex | hematology | 2016 | standard therapy | Poland | 38 |
1412 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Belgium | 9 |
1413 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Slovakia | 30 |
1414 | peripheral blood | Lymphoblastic Lymphoma | hematology | 2016 | standard therapy | Italy | 33 |
1415 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 53 |
1416 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 65 |
1417 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 28 |
1418 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Turkey | 51 |
1419 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 61 |
1420 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | France | 60 |
1421 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Brazil | 37 |
1422 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | United Kingdom | 20 |
1423 | peripheral blood | primary myelofibrosis | hematology | 2016 | standard therapy | Switzerland | 67 |
1424 | peripheral blood | T-cell acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Austria | 41 |
1425 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Czech Republic | 60 |
1426 | peripheral blood | no data | n/a | 2016 | standard therapy | Poland | 44 |
1427 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 63 |
1428 | peripheral blood | myeloproliferative syndrome | hematology | 2016 | standard therapy | Poland | 52 |
1429 | peripheral blood | T-cell acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Serbia | 21 |
1430 | peripheral blood | leukemia | hematology | 2016 | standard therapy | Lithuania | 53 |
1431 | peripheral blood | no data | n/a | 2016 | standard therapy | Turkey | 4 |
1432 | peripheral blood | chronic myelomonocytic leukaemia | hematology | 2016 | standard therapy | Finland | 53 |
1433 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Italy | 52 |
1434 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Spain | 15 |
1435 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Denmark | 68 |
1436 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 66 |
1437 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Israel | 36 |
1438 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Switzerland | 2/3 |
1439 | peripheral blood | myelofibrosis | hematology | 2016 | standard therapy | Netherlands | 66 |
1440 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Belgium | 65 |
1441 | peripheral blood | myelodysplastic syndrome - RCMD | hematology | 2016 | standard therapy | Czech Republic | 32 |
1442 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 59 |
1443 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | United Kingdom | 68 |
1444 | peripheral blood | T-cell acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 19 |
1445 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 32 |
1446 | peripheral blood | no data | n/a | 2016 | standard therapy | Poland | 55 |
1447 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 67 |
1448 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 61 |
1449 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Turkey | 48 |
1450 | peripheral blood | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Netherlands | 38 |
1451 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 18 |
1452 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 46 |
1453 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 65 |
1454 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Turkey | 38 |
1455 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 66 |
1456 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Turkey | 37 |
1457 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Israel | 63 |
1458 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Turkey | 55 |
1459 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 30 |
1460 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Germany | 27 |
1461 | peripheral blood | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Germany | 32 |
1462 | peripheral blood | chronic myeloid leukemia | hematology | 2016 | standard therapy | Germany | 62 |
1463 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Lithuania | 23 |
1464 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Spain | 38 |
1465 | peripheral blood | no data | n/a | 2016 | standard therapy | Netherlands | 58 |
1466 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Australia | 51 |
1467 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 69 |
1468 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 62 |
1469 | peripheral blood | primary Immunodeficiency | hematology | 2016 | standard therapy | Russia | 5 |
1470 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 51 |
1471 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Hungary | 20 |
1472 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Hungary | 46 |
1473 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Estonia | 62 |
1474 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Spain | 58 |
1475 | peripheral blood | myeloma multiplex | hematology | 2016 | standard therapy | Poland | 51 |
1476 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 72 |
1477 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 35 |
1478 | peripheral blood | plasma cell disorder | hematology | 2016 | standard therapy | France | 47 |
1479 | peripheral blood | Fanconi anaemia | hematology | 2016 | standard therapy | Estonia | 7 |
1480 | peripheral blood | myeloma multiplex | hematology | 2016 | standard therapy | Germany | 63 |
1481 | peripheral blood | chronic myelomonocytic leukemia, minimal residual disease | hematology | 2016 | standard therapy | Poland | 50 |
1482 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 52 |
1483 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 38 |
1484 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Belgium | 56 |
1485 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Hungary | 57 |
1486 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Canada | 13 |
1487 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | France | 24 |
1488 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Czech Republic | 37 |
1489 | peripheral blood | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | United Kingdom | 18 |
1490 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Lithuania | 15 |
1491 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | France | 67 |
1492 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 47 |
1493 | peripheral blood | chronic lymphocytic leukemia | hematology | 2016 | standard therapy | Germany | 62 |
1494 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 66 |
1495 | peripheral blood | no data | n/a | 2016 | standard therapy | France | 59 |
1496 | peripheral blood | no data | n/a | 2016 | standard therapy | Germany | 17 |
1497 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Ireland | 47 |
1498 | peripheral blood | primary myelofibrosis | hematology | 2016 | standard therapy | Germany | 67 |
1499 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Australia | 61 |
1500 | peripheral blood | myelofibrosis | hematology | 2016 | standard therapy | Israel | 72 |
1501 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 73 |
1502 | peripheral blood | aplastic anaemia | hematology | 2016 | standard therapy | United Kingdom | 23 |
1503 | peripheral blood | no data | n/a | 2016 | standard therapy | Czech Republic | 59 |
1504 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 43 |
1505 | peripheral blood | T Cell Lymphoma/ NOS - Not otherwise specified | hematology | 2016 | standard therapy | Germany | 55 |
1506 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 66 |
1507 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 32 |
1508 | peripheral blood | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Germany | 32 |
1509 | peripheral blood | no data | n/a | 2016 | standard therapy | Sweden | 58 |
1510 | peripheral blood | myelodysplastic syndrome - RAEB | hematology | 2016 | standard therapy | Poland | 56 |
1511 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 40 |
1512 | peripheral blood | refractory anemia with excess blasts | hematology | 2016 | standard therapy | United Kingdom | 62 |
1513 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Belgium | 46 |
1514 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Slovakia | 8 |
1515 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 13 |
1516 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 42 |
1517 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 64 |
1518 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Germany | 50 |
1519 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Czech Republic | 49 |
1520 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 32 |
1521 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Czech Republic | 56 |
1522 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 29 |
1523 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 46 |
1524 | peripheral blood | no data | n/a | 2016 | standard therapy | Germany | 71 |
1525 | peripheral blood | no data | n/a | 2016 | standard therapy | Belgium | 30 |
1526 | peripheral blood | Wiskott-Aldrich syndrome | hematology | 2016 | standard therapy | Poland | 1 |
1527 | peripheral blood | no data | n/a | 2016 | standard therapy | Czech Republic | 1 |
1528 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Sweden | 35 |
1529 | peripheral blood | no data | n/a | 2016 | standard therapy | Poland | 28 |
1530 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Italy | 31 |
1531 | peripheral blood | adrenoleukodystrophy | metabolic | 2016 | standard therapy | Poland | 1 |
1532 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 18 |
1533 | peripheral blood | primary myelofibrosis | hematology | 2016 | standard therapy | Germany | 50 |
1534 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 54 |
1535 | peripheral blood | T-cell leukemia/lymphoma | hematology | 2016 | standard therapy | Canada | 31 |
1536 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Czech Republic | 54 |
1537 | peripheral blood | Hodgkin’s lymphoma | hematology | 2016 | standard therapy | Poland | 31 |
1538 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 64 |
1539 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Columbia | 43 |
1540 | peripheral blood | no data | n/a | 2016 | standard therapy | Netherlands | 69 |
1541 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Germany | 66 |
1542 | peripheral blood | chronic lymphocytic leukemia | hematology | 2016 | standard therapy | Sweden | 61 |
1543 | peripheral blood | X-linked lymphoproliferative disease | hematology | 2016 | standard therapy | Russia | 12 |
1544 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Poland | 18 |
1545 | peripheral blood | no data | n/a | 2016 | standard therapy | Poland | 43 |
1546 | peripheral blood | no data | n/a | 2016 | standard therapy | Netherlands | 70 |
1547 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | France | 40 |
1548 | peripheral blood | chronic lymphocytic leukemia | hematology | 2016 | standard therapy | Slovakia | 52 |
1549 | peripheral blood | no data | n/a | 2016 | standard therapy | Czech Republic | 45 |
1550 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | Australia | 62 |
1551 | peripheral blood | myelodysplastic syndrome | hematology | 2016 | standard therapy | Austria | 60 |
1552 | peripheral blood | acute lymphoblastic leukemia | hematology | 2016 | standard therapy | Poland | 56 |
1553 | peripheral blood | acute myelogenous leukemia | hematology | 2016 | standard therapy | United Kingdom | 58 |
{{$index+1}} | {{item.source}} | {{item.indication}} | {{item.area}} | {{item.year}} | {{item.therapy}} | {{item.country}} | {{item.age | number}} |